Moderate

Anal fistula (fistula-in-ano)

fistula · GI / Surgical
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

An abnormal track between the anal canal and perianal skin, usually arising from a previous cryptoglandular abscess. Goals are to drain sepsis, define anatomy relative to the sphincter complex and eradicate the track while preserving continence.

Red flags

  • Spreading perianal sepsis / necrotising infection
  • Immunosuppression or diabetes with uncontrolled sepsis
  • Induration or mass suggesting malignancy
  • Multiple complex tracks suggesting Crohn's
  • Faecal incontinence after prior surgery

Assessment

Differential diagnosis

  • Cryptoglandular fistula-in-ano
  • Crohn's perianal fistula
  • Hidradenitis suppurativa
  • Pilonidal sinus
  • Perianal abscess
  • Anal/rectal malignancy
  • Tuberculous or actinomycotic fistula

Investigations

  • Examination and rigid proctoscopy under anaesthesia (EUA)
  • MRI pelvis for complex, recurrent or Crohn's-associated fistulae
  • Endoanal ultrasound as alternative imaging
  • Colonoscopy / small bowel assessment if Crohn's suspected
  • Biopsy of atypical tracks to exclude malignancy
  • FBC, CRP, HbA1c; faecal calprotectin if IBD suspected

Management

  • Drain any associated acute abscess first
  • Perform EUA to define internal/external openings and the track relative to sphincters (Parks classification)
  • Apply Goodsall's rule as a guide to track orientation
  • Classify as intersphincteric, transsphincteric, suprasphincteric or extrasphincteric
  • For simple low fistulae consider fistulotomy (lay-open) with minimal sphincter division
  • For high/complex fistulae place a loose draining seton to control sepsis and preserve continence
  • Plan definitive sphincter-preserving procedures (LIFT, advancement flap, fistula plug) for complex tracks
  • Investigate and co-manage underlying Crohn's disease with gastroenterology
  • Counsel carefully on continence risk before any sphincter division
  • Provide wound care and follow-up after surgery
  • Consider biologic therapy for refractory Crohn's fistulae
  • Safety-net for recurrent sepsis and recurrence

Drugs & doses

Metronidazole 400 mg PO TDS (adjunct, especially Crohn's)
Ciprofloxacin 500 mg PO BD for Crohn's perianal disease
Paracetamol 1 g PO QDS
Stool softener (e.g. lactulose 15 mL BD) to ease post-op defecation
Anti-TNF biologic (e.g. infliximab) for complex Crohn's fistula per gastroenterology

Disposition

Elective colorectal surgical referral for EUA and definitive management; urgent admission for associated acute perianal sepsis. Co-refer suspected Crohn's to gastroenterology.

Complications & pitfalls

  • Faecal incontinence from sphincter division
  • Recurrence or persistence
  • Chronic non-healing wound
  • Progression of undiagnosed Crohn's
  • Rare malignant transformation

Exam pearls

  • Never divide significant sphincter muscle in high transsphincteric fistulae — use a seton and sphincter-preserving techniques
  • MRI is the gold standard for mapping complex and recurrent fistulae
  • Suspect Crohn's with multiple, complex or recurrent fistulae — investigate the whole gut
  • Goodsall's rule guides but does not replace operative assessment of track anatomy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.